Ares Management Corporation (NYSE: ARES) — The Best House on the Private-Credit Block, Still Not on Sale

Independent equity research note. Report date: 2026-06-14. Price reference: ~$134.90 (2026-06-12).

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice and not a recommendation to buy or sell any security. The analysis that follows (sections 1–15) is deliberately position-free and carries no recommendation or price target; this opener is the single exception.

Verdict: HOLD / accumulate only on weakness (sub-~$115). Not a buy at ~$135. This is a top-tier franchise at a fair-to-full price, not a bargain — even after a ~33% fall from its 2025 high. Fair-value zone ~$126–140; I’d want the high-single-digit-percent margin of safety that only appears nearer the bear zone (~$95–110) before adding aggressively. Conviction: medium.

The trap with Ares is to confuse “down a third” with “cheap.” It isn’t. After the private-credit panic of late-2025/early-2026 cut the stock roughly in half peak-to-trough and then let it rebound ~40%, ARES still sits at the 77th percentile of its own ten-year valuation range (on price-to-sales, the only own-history gauge GAAP doesn’t corrupt) and trades at the richest multiple of the large-cap alternative managers — ~25x trailing fee-related earnings, ~21x forward — on the lowest FRE margin of the group (~42–48% vs. KKR’s ~69%). The market is not mispricing the franchise downward; it has simply repriced it from euphoric (~30x at the 2025 peak) to merely expensive. The genuine contrarian, left-for-dead name in this cohort is Blue Owl (OWL) at ~12x and a 9% yield; ARES is the premium-priced quality name that fell in sympathy. The factor tape agrees: ARES screens as a high-beta (1.55), credit-spread-levered, negative-Value (i.e., growth-profiled) stock — not a value or momentum name — and its current move is a recovery off a characteristic ~50% drawdown (this stock has a -49.7% max drawdown in its 10-year, 30%-CAGR record), not a falling knife and not a deep-value dislocation.

So why own it at all, and why “accumulate on weakness” rather than “avoid”? Because the underlying business is one of the best compounders in financials: ~26% AUM CAGR for five years, FRE +30% and RI +26% in 2025, the highest fee-durability mix in the peer group (93% of fees from perpetual or long-dated capital), ~$730M of already-contracted embedded fee growth (23% of base fees) sitting in undeployed capital, founder Tony Ressler’s ~20% personal stake, a director buying stock in the teeth of the selloff, and a dividend compounding ~20% a year (just raised to $1.35/quarter). The framing is quality-at-a-full-price, priced for the soft landing it will probably get. The whole debate reduces to one variable — the private-credit cycle. Single piece of evidence that flips me bullish: two-to-three more quarters of ≥18% FRE growth with benign direct-lending credit metrics while the multiple stays ~20x, i.e., the algorithm proven through the cycle at a non-euphoric price. Single piece that flips me bearish: a genuine default cycle — rising direct-lending non-accruals, broadening BDC/retail redemptions, and forced marks — which would compress growth and the multiple simultaneously, with the stock starting from a rich, high-beta base. Tag: a Ferrari at a fair price — magnificent machine, but you’re not stealing it, and it corners at 50% drawdowns.

1. Executive Summary

Ares Management is a global alternative asset manager — a capital-light “toll road on private capital” that raises long-dated third-party money, deploys it across credit, real assets, secondaries and private equity, and earns recurring management fees on assets under management plus a modest layer of performance income. At year-end 2025 it managed $622.5 billion of AUM (up 29% year-on-year), of which $384.9 billion was fee-paying (up 32%), generating $3.68 billion of management fees (up 25%), $1.78 billion of fee-related earnings (FRE, up 30%) and $1.85 billion of realized income (RI, up 26%). It is the largest player in its core battleground — direct lending / private credit, where Credit is 65% of AUM and direct lending alone is $274 billion — and it externally manages Ares Capital Corp (ARCC), the largest publicly traded BDC.

The investment tension is clean. On quality, ARES is genuinely top-tier: a real, durable moat built on economies of scale plus customer captivity (locked, long-dated capital), a 20-year loss-rate track record, and a fundraising flywheel; the highest fee-durability mix of the major alternatives (93% of fees from perpetual/long-dated capital); ~26% five-year compounding across every operating metric; and an unusually large, contractually committed embedded-fee tailwind ($730M, 23% of base fees) that de-risks near-term growth almost regardless of new fundraising. Capital allocation is above-average for the sector — a disciplined dividend anchored to after-tax FRE (not GAAP), conservative corporate leverage once non-recourse fund debt is stripped out, and founder/insider alignment among the best in the group.

On price and cycle, the picture is more cautious. ARES carries the richest multiple in the peer group on the lowest FRE margin, and it sits in the upper-middle-to-expensive band of its own valuation history even after a ~33% drawdown — the selloff corrected an overshoot rather than creating value. Its earnings are, by the model’s design, levered to one asset class — private credit — at the exact moment (June 2026) that the asset class is working through a retail-redemption-driven, record-default down-leg (Fitch pegged the US private-credit default rate at ~6.0% in April 2026). ARES’s own retail private-credit exposure is small and quantified (≈4.5% of fee-paying AUM; ~1% of FPAUM of annual downside in a stress case), and its $100B+ of credit dry powder positions it as a consolidator in the shake-out rather than a casualty. But the stock is a high-beta vehicle (β ≈ 1.55) with a history of ~50% drawdowns, and the central risk is that a deeper, longer credit cycle compresses growth and multiple together.

This memo values ARES strictly on non-GAAP per-share metrics (FRE, after-tax RI) and a properly de-consolidated enterprise value — GAAP EPS and the screen-reported 48–82x “P/E” are artifacts of consolidated-fund accounting and are discarded. The body takes no position and sets no price target; it lays out the embedded expectations, the scenario zones, and the falsification tests on both sides.

2. Business Overview

2.1 What Ares is and how it makes money

Ares Management Corporation, founded in 1997 and public since 2014 (NYSE: ARES), is a global alternative asset manager headquartered in Los Angeles, led by co-founder/CEO Michael Arougheti, with co-founder Antony Ressler as Executive Chairman. It employs ~4,250 people including ~1,700 investment professionals across 55+ offices, and was added to the S&P 500 in December 2025. Critically for the per-share analysis, ARES is a C-corporation (not an Up-C/MLP like Blue Owl), which simplifies its share-count and reduces the structural complexity that complicates peers.

The economic model is a fee machine. ARES raises capital into funds and vehicles, earns a recurring management fee on assets under management (the durable, annuity-like core), supplements it with performance income (carried interest and incentive fees — a minority of profit), and runs a small balance-sheet investment book. The business is capital-light: incremental AUM costs little incremental capital, so scaled growth drops disproportionately to earnings — in principle. (In practice, as §6 shows, ARES has converted scale into AUM and fee growth faster than into margin.)

2.2 Segment structure (FY2025)

(Segment AUM sums above the $622.5B total because the ~$86B insurance platform is counted across strategies; “Other” carries only the discrete $9.1B. Source: FY2025 10-K, Business §.)

2.3 The quality signatures

Recurring fee dominance. Management fees of $3.68B (FY2025) crossed $1.0 billion in a single quarter for the first time in Q1 2026 (+22% YoY). Net realized performance income was only ~$169M of RI — ARES is a fee machine, not a carry P&L (FRE was 96% of RI in 2025). This is the highest-quality, most predictable earnings mix in the large-cap group: less torque on a carry up-cycle, but far more annuity-like.

Fee durability. 93% of FY2025 management fees came from perpetual capital or long-dated funds (95% in FY2024) — among the highest in the industry, comparable to OWL. Average remaining contract terms on non-perpetual funds run multi-year by strategy (US/EU direct lending ~5.5 years, secondaries ~8.1 years, liquid credit ~9.3 years). This is contractual, locked revenue, not redeemable daily-priced AUM.

The ARCC anchor. Ares Capital Corp (NASDAQ: ARCC) is the largest publicly traded BDC, externally managed by ARES at 1.50% of assets plus incentive fees, with a 21-year track record (≈12.4% average annual total return, ≈2x the syndicated-loan index) and a 1.2% non-accrual ratio. ARCC is permanent, perpetual-fee capital and the franchise’s proof-of-concept.

Three distribution channels. (1) Institutional (76% of AUM, $470B; 2,850+ relationships, up from 1,090 in 2020) — the core. (2) Wealth (Ares Wealth Management Solutions): $66–68B, +69%/+54% YoY across eight products on 80 platforms, including a new US direct-lending 401(k) product. (3) Insurance (Ares Insurance Solutions / affiliated insurer Aspida): ~$86B insurance-related AUM (+20%). Note ARES’s insurance model is asset-light — it manages insurance balance sheets rather than owning them, unlike APO/Athene or KKR/Global Atlantic. That means less spread/credit risk on ARES’s own balance sheet, but also less captured spread economics.

The wealth and insurance legs deserve emphasis because they are the two channels most likely to define the next decade of fee growth, and they behave very differently. Wealth (AWMS) is the higher-fee, higher-beta channel: its semi-liquid/perpetual products (the non-traded BDC ASIF, the AREIT and AIREIT non-traded REITs, a core-infrastructure vehicle, European direct lending, secondaries, and a sports/media/entertainment fund) carry institutional-grade management fees plus, in several cases, incentive fees, and they raised at a ~$1B/month-plus clip through 2025. The flip side is that semi-liquid retail vehicles are precisely where the June-2026 redemption stress concentrates, so the channel is both the fastest-growing and the most cyclically sensitive piece of the franchise. Insurance (AIS/Aspida) is the mirror image: ~0.28% blended fee (tiered down from 0.30% to 0.15% as balances scale), but exceptionally sticky, investment-grade, and slow-redeeming — Aspida’s own annuity sales grew ~39% to $8.8B in 2025, and a growing slice of AIS AUM is sub-advised back into Ares credit vehicles, so insurance simultaneously feeds the credit machine and locks in low-cost permanent-style capital. The strategic logic is that the two channels hedge each other across the cycle: wealth supplies fee-rate and growth in benign markets, insurance supplies durability and origination demand when retail flows cool.

The ARCC relationship also merits a fuller accounting because it is the single best public proof of the whole model. Ares Capital Corp is not just a fee payer — it is a 21-year, publicly auditable track record that ARES uses as its fundraising calling card: ~12.4% average annual total return since its 2004 IPO (roughly double the leveraged-loan index), $70B+ deployed and exited at a ~13% asset-level gross IRR, and a non-accrual ratio of ~1.2% at fair value through multiple credit cycles including the GFC and COVID. Because ARCC is permanent, exchange-listed capital paying 1.50% of assets plus incentive fees, it is both a perpetual-fee anchor and a live, third-party-verified answer to the central bear question — “can a direct lender actually avoid losses through a downturn?” The honest caveat is that ARCC’s record was built largely in a 15-year era of falling-to-low rates and benign defaults; the current cycle is the first real test at today’s scale.

Verdict (Business Overview): A genuinely high-quality, recurring, capital-light fee model with the broadest product shelf in alternatives and the #1 franchise in its largest category. Two honest qualifications carry through the memo: (1) the FRE margin is the lowest of the majors — scale has shown up as revenue faster than as margin; and (2) the model is disproportionately exposed to private credit at a cyclically awkward moment.

3. Industry Dynamics

3.1 Structure

Alternative asset management is an oligopoly-with-a-long-tail: a handful of scaled global platforms (BX ~$1.24T, APO ~$840B–$1T, KKR ~$660–760B, ARES ~$622B, plus Brookfield, Carlyle, OWL, TPG) capture a rising share of institutional and retail flows beneath thousands of sub-scale specialists. The structurally attractive feature is that customer capital is contractually locked for years (or permanently), so revenue is far stickier than in traditional, redeemable asset management — which is precisely why alternatives command premium multiples to the T. Rowe / Franklin cohort.

3.2 The private-credit capital cycle (the decisive framing)

Because Credit is 65% of ARES’s AUM, the Marathon capital-cycle lens on private credit is the analytically decisive question.

Capital has unambiguously flooded in. The global private-credit market roughly tripled to ~$1.7T (sell-side projections run to $2.6T by 2029 and higher). Spreads compressed ~100bps from the 2021 peak; the direct-lending premium over broadly syndicated loans narrowed to ~100bps as banks re-entered; fund time-in-market stretched past 23 months (longest since 2008); and — the textbook late-cycle “sell to the public” signal — the marketing frontier moved from institutions to retail wealth channels (non-traded BDCs).

The down-leg is live. As of June 2026 the sector is working through a private-credit redemption wave that began in late 2025: Fitch’s US private-credit default rate hit a record ~6.0% (April 2026); peer Blue Owl gated a non-traded BDC, force-sold ~$1.4B of loans, and disclosed ~40.7% redemption requests on one retail fund; BDCs trade at 27–34% NAV discounts. This is a genuine Marathon bust-phase signal — the fastest-growing, most-marketed retail vehicles are the most stressed, exactly as the asset-growth anomaly predicts.

Where ARES sits — better-positioned than most, not immune. ARES quantifies its retail private-credit exposure tightly: the two US private-credit wealth products are ~4.5% of FPAUM; a full year of 5%-quarterly redemptions with zero gross inflows would cost only ~1% of FPAUM annually — versus 19% FPAUM growth in the trailing year. Critically, the cycle is two-sided: ARES holds $100B+ of credit dry powder (most of any public player) and permanent capital, so it lends into a lender-friendly next vintage (wider spreads, lower leverage, better terms) while redemption-constrained competitors are forced sellers. Management’s claim that ARES grew fastest during the GFC and COVID is consistent with the capital-cycle survivor dynamic.

Counter-evidence management cites (treat as hypothesis, not evidence): corporate-credit-to-GDP unchanged over a decade (private credit is substituting for bank/syndicated lending, not adding leverage); private credit contracted only once in 25 years vs. banks eight times; direct-lending portfolio EBITDA growth ~10%, LTV mid-40s%, interest coverage 2.2x. These are real and largely corroborated by ARCC’s filings — but they describe ARES’s own book; the industry-wide ~6.0% default rate is the disconfirming datum to weigh.

The bank-disintermediation mechanism — why the demand side is structural, not faddish. It is worth being precise about why private credit grew, because it determines whether the asset class mean-reverts (a Marathon bust) or merely re-prices within a secular up-trend. Post-GFC capital rules (Basel III, the leveraged-lending guidance, and most recently the “Basel III endgame” proposals) made it progressively more expensive for deposit-funded banks to hold middle-market and leveraged loans on balance sheet. That capital cost did not eliminate the borrowers’ need for credit; it relocated the lending to non-bank vehicles funded by long-dated institutional and insurance capital — a regulatory-arbitrage shift that is durable for as long as the rules stand. The implication for the cycle read is nuanced: the demand for private credit is structurally supported (it is taking share from banks, not inflating total leverage), but the supply of capital chasing that demand has overshot, compressing spreads and loosening terms — a classic Marathon late-cycle configuration where a good long-run story attracts too much capital in the short run. Both can be true at once, and they are: the secular winner can still suffer a cyclical loss-and-redemption episode. ARES’s bet is that it survives the cyclical episode with enough dry powder to compound through it; the bear’s bet is that the episode is deeper than a diversified fee base can absorb.

3.3 Secular tailwinds (the demand-side bull case)

1. Bank retrenchment from lending — post-GFC regulation pushed middle-market/leveraged lending out of deposit-funded banks into non-bank direct lenders. Structural, multi-decade.
2. Retirement/401(k) democratization — Executive Order 14330 (Aug 2025) plus a DOL/EBSA proposed safe-harbor rule (Mar 2026) to open defined-contribution plans to private assets. ARES launched a 401(k) direct-lending product in Q1’26. Potentially the largest new demand pool — but mis-timed, since the rule conditions access on “timely and accurate valuation,” exactly what the June-2026 mark-and-redemption crisis calls into question.
3. Insurance general-account outsourcing — insurers outsourcing asset management to alternatives; ARES’s AIS/Aspida and third-party insurance AUM ($86B, +20%) ride this.
4. Wealth under-allocation — individual private-market allocation is still only ~3–4%, implying a long runway even after $300B of trailing-three-year retail inflows.
5. Data-center / AI infrastructure super-cycle — ARES sizes the third-party data-center market at ~$900B; its Ada Infrastructure platform (ex-GCP) is vertically integrated, with a global data-center equity fund in market.

3.4 Regulation and competitive intensity

Net regulatory posture is a tailwind (bank disintermediation + 401(k)/retail access + insurance outsourcing) with a near-term retail-protection overhang (SEC 2026 exam priorities flag pushing alternatives to retail; BDC redemption mechanics under scrutiny). Competition is intensifying for capital (top-10 funds took a record ~46% of 2025 commitments — concentration favoring scale leaders like ARES) and for assets (spread compression at the margin). The Marathon read: a favorable supply side for scaled survivors, unfavorable for sub-scale entrants and retail-flow-dependent managers.

Verdict (Industry Dynamics): STRUCTURALLY GOOD industry for scaled incumbents, with a genuine cyclical cloud. The long-run demand drivers are real and durable; the locked-capital model makes the revenue structurally attractive. But private credit is demonstrably in a late-cycle/early-bust phase. The industry is good; the entry point in the cycle is the risk. ARES — diversified, dry-powder-rich, permanent-capital scale leader — is among the best-positioned to be a beneficiary rather than a victim of the shake-out, but that is the thesis to falsify, not a given.

4. Competitive Position

4.1 The moat — named in the Greenwald taxonomy

ARES’s advantage is a combination of (1) economies of scale + customer captivity (the strongest, most durable Greenwald type), (2) intangibles — track record / brand / fundraising flywheel, and (3) switching costs embedded in locked, long-dated capital.

Economies of scale + captivity (the real moat). Direct lending and asset-based finance exhibit genuine scale economics: a larger origination platform (1,700 professionals, 55 offices, covering 520+ US and 435+ European sponsors) sees more deals, can be the lead/sole lender controlling terms and pricing, can write $1B+ tickets, and can offer “certainty of capital” that sponsors pay up for — especially in volatile windows, when ARES “gains considerable market share.” The flywheel is self-reinforcing: scale → better selection (≈5% deal yes-rate) and incumbency (≈50% of direct-lending deployment from existing relationships) → lower loss rates (≈1bp/yr net realized losses in US direct lending over 20 years; ARCC 1.2% non-accrual) → stronger track record → more fundraising → more scale. The captivity is the locked capital — 93% of fees from perpetual/long-dated vehicles that cannot walk away annually.

The moat ties to a financial outcome (the Greenwald test). Without scale and incumbency, ARES’s loss rates would rise and its fee durability would fall — franchise margin would deteriorate. That is the test, and it passes. Market-share-stability test: ARES has been a top-tier alternative manager and #1/#2 direct lender for over a decade (dominant-firm longevity = pass).

The honest tension — the moat shows in growth/durability, not margin. The cleanest moat-to-number tie on the capital-light side is normally FRE margin — and here ARES is the weakest of the majors (~42% vs. KKR 69%, BX/OWL/APO ~57–58%). Why? (a) Mix — a heavy weighting to lower-fee liquid credit, ABF, and 0.28% insurance AUM dilutes blended margin; (b) ARES runs a labor-intensive, self-origination model (1,700 pros) rather than a lighter-touch allocator model; © GCP integration costs and a currently FRE-negative data-center build depress margin (management guides both to turn accretive). The bull reading: margin is structurally depressed by deliberate growth investment, with room to expand. The bear reading: a ~42% FRE margin after 28 years and $622B of AUM is evidence the model simply does not operate-leverage like KKR’s.

4.2 Direct comparison vs. peers (FY2025)

Read: ARES is the scale leader in private credit / direct lending specifically — its battleground — and has the highest fee-durability mix (93%), but the lowest FRE margin and less carry optionality than KKR/BX/APO. Versus OWL (the closest comp), ARES is ~2x larger and far more diversified (OWL is ~3 platforms; ARES is 5 groups / ~20 credit strategies), and has been dramatically less affected by the redemption wave (ARES retail PC = 4.5% of FPAUM with quantified ~1% downside; OWL gated a fund and force-sold). That diversification is itself a competitive advantage in this cycle.

4.3 Pressure-test

• Network effects: weak/none in the strict sense — the “more sponsors → more deals” dynamic is scale + incumbency, not a two-sided network. Reject.
• Switching costs: real but moderate — locked capital is contractual, not preference-based; LPs can decline the next vintage. The stickiness is the multi-year/perpetual structure.
• The genuine, durable edge is scale-driven origination + a 20-year loss-rate track record + a locked fee base. Without it, loss rates rise and fundraising slows — a measurable outcome. It is a real moat.

Verdict (Competitive Position): DURABLE ADVANTAGE — the #1 franchise in the largest, most contested alternative category, built on genuine economies of scale + customer captivity and a 20-year track record, with the highest fee-durability mix in the group. The caveat is that the moat shows up in growth and durability more than in margin: ARES’s FRE margin is sector-low, so either the model is structurally less profitable than KKR/BX or there is real, un-harvested operating leverage. Management bets on the latter; the evidence so far (margin only +0.2pts in FY2025, +0.9pts in Q1’26 despite massive scale) is modest. Not a crowded-market weak-differentiation situation — a clear, scaled leader whose quality is one notch below the very best capital-light compounders in the group.

5. Growth — History and Forward Opportunities

5.1 The record (FY2020 → FY2025)

• Total AUM: ~$197B → $622.5B ≈ 26% CAGR.
• FPAUM: to $384.9B, +32% in FY2025 alone.
• Management fees: to $3.68B, +25% YoY; Q1’26 +22%.
• FRE: +30% FY2025 ($1,361.7M → $1,775.3M); ~26% five-year CAGR.
• RI: +26% FY2025 ($1,467.1M → $1,848.3M); ~20% five-year CAGR.
• Institutional relationships: 1,090 (2020) → 2,850+ (2025).
• Wealth AUM: to $66–68B, +69%/+54% YoY.
• Dividend: raised 20% to $1.35/qtr for Q1 2026.

This is a decade-plus of ~25%+ compounding across every operating metric — among the best growth records in financials.

5.2 Organic vs. acquired

Both. Organic dominates — record $113B FY2025 fundraising was achieved “without the two largest private-credit campaign funds in the market.” Acquired growth is real and recurring: GCP International (GLP ex-Greater China), closed March 1, 2025, added ~$46B of AUM (~$31.6B FPAUM), vaulted ARES into the global top-3 industrial real estate owners, and brought the Ada Infrastructure data-center platform. The 2021 Landmark deal (secondaries, now a $42B segment) demonstrates competent integration. Management is openly weighing scaling PE inorganically — while cautioning that PE “is not a growth business” and any deal must clear high accretion bars.

5.3 The embedded-growth engine (“shadow AUM”) — the key quality signal

The most important forward-growth datum: AUM not yet paying fees of $78.8B available for deployment + $4.3B of development assets = ~$730 million of potential incremental annual management fees, a 23% embedded growth rate on 2025 base management fees. This is contractually committed capital that converts to fees as it deploys, regardless of new fundraising — the highest-visibility, lowest-risk growth in the model, and it is enormous. Total available capital/dry powder is ~$156–158B ($100B+ in credit). This is what underwrites management’s confidence that even a retail-redemption shock has “minimal” impact.

5.4 Forward opportunities

1. Flagship credit super-cycle: three of the largest institutional PC funds in market over ~12 months — ASOF III (opportunistic, closed >$8.3B equity), ABF Pathfinder III (oversubscribed, ~$6.6B+ at hard cap), and two new US senior DL vehicles including a new unlevered evergreen core product (SDL III raised $15.3B vs. a $10B cover). EU DL VII in early 2027.
2. Wealth: $68B and +54% YoY, still ~3–4% individual allocation — long runway; eight semi-liquid products expanding into infrastructure, REITs, EU DL, secondaries, plus the new 401(k) leg; a reaffirmed $125B 2028 wealth fundraising target.
3. Insurance / AIS: $86B (+20%); expanding private-investment-grade origination (ABF private-IG earned ~200bps over IG corporates) for Aspida + third-party insurers. Asset-light, sticky.
4. Digital infrastructure / data centers: ~$900B third-party TAM; vertically integrated Ada platform; a global data-center equity fund with a major first close expected summer 2026; the data-center business turning from FRE-negative to FRE-accretive (a margin tailwind). X-energy (nuclear) marked from ~$100M cost to ~$700M fair value — balance-sheet optionality.
5. Secondaries: least-capitalized alt segment; GP-led now ≥50% of the opportunity; all four asset-class verticals built; credit secondaries was ARES’s largest-ever inaugural institutional raise (~$4B equity / $7B+ with leverage).
6. Stated targets: longer-term 16–20% FRE CAGR, 20–25% RI CAGR, ~20% dividend growth, with FRE-margin expansion guided toward the upper end of 0–150bps/yr.

5.5 Quality of growth

• High-quality on durability: organic, fee-centric, perpetual/long-dated, with a massive contracted embedded-fee tail ($730M / 23%) that de-risks the next 1–2 years almost regardless of markets.
• High-quality on breadth: ~20 credit strategies + real assets + secondaries means “when one is turned off, another is turned on” — Q1’26 showed exactly this (US DL slowed on a 41% drop in middle-market M&A, while EU DL, real estate, alternative credit, infra and secondaries surprised up).
• The honest caveat: growth has not yet translated into peer-level margin — ARES converts scale into AUM/fees faster than into FRE-margin operating leverage. Growth is being bought with people, offices and acquisitions. Whether GCP synergies, the data-center inflection, and back-office automation finally lift the margin is the open question that decides whether this is high-quality compounding or merely high-quality expansion.

Verdict (Growth): HIGH-QUALITY GROWTH — among the best, most durable, most visible records in financials, organic-led, perpetual-capital-backed, with an unusually large contracted embedded-fee runway and multiple credible new legs. The one material asterisk is that 26% AUM CAGR has produced only a ~42% FRE margin — so the growth has so far been more scale accumulation than margin compounding. If the guided margin expansion materializes, ARES is a top-tier compounder; if not, it is a fast-growing but structurally lower-margin fee machine.

6. Financial Quality

6.1 The GAAP problem (read this first)

ARES’s consolidated GAAP statements are nearly useless as a profit gauge. The income statement grosses up the revenues and expenses of Consolidated Funds it is deemed to control, then strips out almost all of it via non-controlling interests ($253.9M of Consolidated-Fund NCI in FY2025; $1.50B of AOG-unit NCI equity). GAAP net income to common was $426M / $1.96 EPS in FY2025 — and the GAAP dividend payout ratio was 107%, GAAP ROIC ~3.5%, GAAP ROA ~2% — all artifacts of consolidation, not the real business. The economics live in FRE, RI, FRPR and net realized performance income. Everything below is built on those and reconciled to GAAP where it matters.

6.2 Five-year non-GAAP earnings power ($M)

The headline: FRE compounded ~26% over five years and grew 30% in FY2025 alone; RI grew 26%. And the quality of that growth is exceptional — it is driven by the durable side of the model. FRE was 96% of RI in FY2025, with net realized performance income only ~$169M. ARES’s realized profit is overwhelmingly recurring, contractual management-fee income — not volatile carried interest. The trade-off is less torque on a carry up-cycle; the benefit is annuity-like predictability. (A reservoir of future carry exists: FY2025 GAAP carried-interest allocation was $1,154M and total unrealized performance income $762.5M — a tailwind that converts to RI over time but is not yet in run-rate.)

6.3 The AUM → FPAUM → fee → FRE bridge

FY2025’s $138B AUM jump was ~$46B from GCP + ~$72B new equity commitments + ~$41B new debt commitments + $27.9B market appreciation, net of distributions/redemptions. FPAUM rose $292.6B → $384.9B (+31.5%). Management fees $2,942M → $3,680M (+25%), with the Credit Group alone producing $2,529M (~69% of firm fees). FRE margin sits in the low-to-mid-40s and has been roughly stable-to-improving while FRE nearly doubled in three years — operating leverage is real but partially reinvested.

The segment composition of FRE is where the “lowest margin in the group” debate is actually settled. Credit is not only the largest fee contributor but the highest-margin engine, because direct-lending and ARCC fees carry low incremental cost once the origination platform exists; Real Assets, by contrast, is currently dilutive to blended FRE margin because the GCP-acquired logistics/digital-infrastructure business is mid-build — its data-center development arm runs FRE-negative today (development spending precedes the fee-paying fund) and is guided to turn FRE-accretive as the global data-center equity fund deploys. In other words, a meaningful slice of ARES’s margin “gap” versus KKR is not structural inferiority but the timing of a specific, identifiable investment (GCP/Ada) that management expects to invert from a margin drag to a margin tailwind over the next one-to-two years. That is the bull’s strongest quantitative hook on the margin question — and it is testable: if Real Assets FRE margin climbs as the data-center fund deploys, the thesis is confirmed; if blended FRE margin stays stuck in the low-40s through 2026 even as GCP integrates, the bear’s “structurally lower-margin model” reading wins.

On returns, the GAAP ROE/ROIC figures (~2–3.5%) are meaningless consolidation artifacts and should be discarded entirely. The economically correct lens for a capital-light manager is return on the capital actually tied up in the business — and on that basis ARES earns very high returns: FRE of ~$1.78B is generated against a modest base of corporate equity and ~$3.94B of corporate debt, with capex of only ~$72M. The “invested capital” that matters is the firm’s balance-sheet investments in its own funds (co-investment/GP commitments) plus goodwill from M&A; against that, realized income of ~$1.85B represents a strong cash return. The cleaner way to say it: ARES converts management contracts and a few thousand professionals into ~$1.8B of recurring cash earnings with almost no physical capital intensity — the return on tangible operating capital is extremely high, which is exactly why the equity commands a premium multiple. The reservoir of unrealized carried interest ($762.5M at year-end, with $1,154M of GAAP carry allocation accrued) is a further, off-balance-sheet store of future realized income that the fee-centric model does not yet reflect in run-rate RI — a source of upside torque the bear case tends to ignore.

6.4 SBC — the $740M jump (the biggest QoE caveat)

Equity compensation more than doubled: $352.9M (FY2024) → $740.5M (FY2025). Drivers: ~$110M of GCP-acquisition immediate-vesting equity comp + $48.5M of other acquisition-related comp (i.e., a chunk is deal-related/non-recurring), plus a larger grant program against a higher stock price and post-GCP headcount growth. FRE and RI add back equity comp, so headline non-GAAP growth is flattered by the exclusion of a fast-growing, increasingly stock-funded comp expense. Net share settlement consumed 2.3M shares in FY2025 and taxes paid on net settlement were $436.9M — a real cash cost the non-GAAP measures partly obscure. The $740M SBC is the single largest quality-of-earnings blemish and deserves an explicit haircut in valuation.

6.5 Balance sheet — corporate leverage vs. non-recourse fund debt (critical)

The headline “net debt ~$14B” is misleading and must be decomposed:

Real corporate leverage is modest: ~$3.94B face against FRE $1,775M ≈ 2.2x FRE (≈1.9x net of $489M cash) — comfortably investment-grade-consistent. The ~$9.6B of CLO/fund debt is non-recourse to Ares except to the extent of its fund investments and must be excluded from any leverage or EV calculation. The revolver was upsized to $1.84B in April 2025 (maturity extended to 2030) and primarily financed the GCP cash consideration — so leverage stepped up in 2025 but remains conservative relative to FRE. Liquidity: $489M cash + $460M revolver availability; the regulatory net-capital requirement is only ~$99M.

6.6 Cash generation

Core operating cash flow (ex-funds) was $1,727M in FY2025 vs. $1,095M in FY2024 (+58%); total-company operating cash flow $2.1B exceeded RI of $1.85B. This is a cash-generative compounder, not an accrual mirage — the only nuance being the SBC add-backs noted above.

Verdict (Financial Quality): YES, economics improve with scale — with an asterisk. ARES shows classic asset-light, high-incremental-margin economics: ~26% FRE compounding, a ~96%-durable fee-income base (the highest-quality mix in the group), 23% of forward fee growth already contracted, and conservative corporate leverage once fund debt is stripped out. The asterisk is SBC: equity comp doubled to $740M and is excluded from the very non-GAAP measures the thesis rests on, so true per-share economics dilute faster than FRE-per-share growth implies. Net: a high-quality, scaling, cash-generative model — but discount the non-GAAP optics for ~$0.7B/yr of stock comp.

7. Capital Allocation

7.1 Dividend policy (anchored to FRE, not GAAP)

The common dividend was raised 20% to $1.35/qtr ($5.40 annualized) for Q1 2026 (prior run-rate ~$1.12/qtr), continuing a long cadence of high-teens/20% annual increases. Crucially, the dividend is set against FRE after an allocation of current taxes — not GAAP earnings — so the 107% GAAP payout is irrelevant. With after-tax FRE of ~$1,510M, the payout sits in the ~60–70% range, sustainable and leaving room for the guided ~20% growth. Total dividends and distributions paid (incl. AOG units + preferred) were $1,756.7M in FY2025. A known, dated dilution event to flag: the $1.46B Series B 6.75% mandatory convertible preferred auto-converts to Class A on October 1, 2027 (~30M shares).

7.2 Share count — the dilution criticism

Share count has risen materially — the principal capital-allocation demerit. Class A common rose 199.9M (2024) → 218.5M (2025); fully-exchanged (incl. non-voting + AOG/Class C units) is ~327M. Versus 2020, Class A is up ~50%. Sources: GCP equity consideration (9.6M Class A + a $1.66B equity slug), a 2024 $407M follow-on, and ~2.3M net SBC shares/yr after net settlement, with the Oct-2027 preferred conversion still to come. There is no meaningful buyback — ARES is a net issuer, funding M&A and comp with equity. This is the textbook alt-manager trade-off: rapid FRE growth partly bought with dilution. Investors are compensated because FRE-per-share still rises (FRE +30% >> share count +9% in 2025), but the margin of safety on dilution is thinner than at peers that buy back stock.

7.3 M&A history

GCP economics: $3.92B initial = $1.79B cash + $1.66B equity (9.6M shares) + $465M contingent; allocation ~$1.33B intangibles + $2.29B goodwill (only $1.1B tax-deductible). ARES paid a full price — ~88% of value in goodwill + intangibles — a bet on scaling a new logistics/digital-infra franchise into the GCP fund pipeline. Early returns look directionally accretive (Real Assets FRE more than doubled $212M → $465M, AUM nearly doubled), but the deal is recent and the contingent/earn-out structure means the true multiple paid won’t be known until milestones resolve. This is the most consequential capital-allocation decision of the period and carries the most execution risk.

Viewed through the Marathon capital-cycle lens, ARES’s M&A pattern is the part of capital allocation most worth watching, because the discipline that protects an alternative manager is not buying assets at the top of a cycle it understands better than anyone. The Landmark (secondaries, 2021) and AMP infrastructure-debt (2022) deals look, in hindsight, like additions of capacity in under-supplied niches — secondaries in particular remains one of the least-capitalized alternative segments, which is exactly where Marathon’s framework says to add. GCP is harder to grade: logistics real estate and data-center development are not under-supplied in 2025–26 — data-center capital is, if anything, in a frenzy — so the deal is better understood as a platform/talent acquisition (buying an operating capability and a fund pipeline) than as a contrarian capacity bet, and the ~88%-goodwill price reflects that. The reassuring counter-evidence is twofold: management financed roughly half of GCP with stock issued near a then-elevated share price (using a rich currency to buy, the correct direction), and it has been explicit that any future PE consolidation must clear a high accretion bar — i.e., it is aware of cycle timing. The thing to monitor is whether the next large deal is another full-priced platform purchase into a hot category (a yellow flag) or a contrarian capacity addition into a starved one (a green flag). On balance, ARES has earned the benefit of the doubt on M&A discipline, but GCP is the open verdict.

7.4 Comp and incentive alignment

NEO compensation runs “primarily through carried interest and incentive fees and equity awards.” Co-founder/director-NEOs (Arougheti, deVeer) received no base salary or cash bonus in 2025 — they are paid through carried-interest participation and equity, eating from the same fund economics as LPs. Non-founder NEOs receive salary/bonus (CFO Phillips $750K + $1.25M, etc.). Carried interest vests over 5 years with clawback/contingent-repayment — the right structure (LP-aligned, performance-gated, deferred). Say-on-pay passed at 92.3%. The one caveat: the absence of an explicit FRE-per-share or TSR metric means comp rewards AUM/fund growth and fund performance, which can tolerate dilution.

7.5 Founder ownership — the alignment anchor

Antony Ressler (co-founder, Executive Chairman) holds ~19.68% of Class A on a fully-exchanged basis — a multi-billion-dollar personal stake. Founders/insiders collectively control the firm via Class B/C and AOG units. Alignment of long-term economic interest is excellent; the governance trade-off is concentrated control (founder-controlled, limited public-float voting power).

Verdict (Capital Allocation): QUALIFIED YES. Disciplined, FRE-anchored dividend with a sustainable payout funding ~20% growth; conservative corporate leverage; best-in-class founder/insider alignment; founders paid through fund carry, not salary. Two demerits: persistent dilution (net issuer, no buyback, funding M&A and comp with stock) and a full-priced, goodwill-heavy, integration-risk GCP bet whose true return is unproven. Above-average capital allocation for the sector — watch the dilution and the GCP earn-out.

8. Changes and Headwinds — Last Two Years

1. GCP International closed March 1, 2025 — the transformational event; created APAC real estate equity and a new digital-infrastructure platform; added ~$46B AUM and 278 professionals; drove Real Assets FRE $212M → $465M. Largest deal in firm history; financed with revolver draw + equity.
2. Segment realignment (Q1 2025) — combined real estate + infrastructure into one Real Assets Group and changed interest-expense allocation; affects segment comparability.
3. AUM crossed $622.5B (+49% over two years); added to the S&P 500 in December 2025.
4. Dividend hikes — ~20%/yr, reaching $1.35/qtr; multi-year targets reaffirmed (16–20% FRE / 20–25% RI / ~20% dividend CAGR).
5. Capital-structure events — Oct 2024 $1.46B Series B 6.75% mandatory convertible preferred (converts Oct 2027) + $407M Class A follow-on + $736M senior notes; April 2025 revolver upsize to $1.84B.
6. Leadership/governance — dual Co-President structure (deVeer, Jacobson); Phillips CFO; the Executive Management Committee and equity-incentive committee were dissolved in Feb 2025 with duties moved to the full Board (a governance centralization).
7. Insurance/perpetual-capital build-out continues (Aspida, ASIF non-traded BDC, perpetual wealth vehicles, private-IG origination). Mild headwind: elevated redemption requests in two newer retail/semi-liquid funds (~5% of AUM), concentrated in a few family offices/Asian investors; >95% of investors did not redeem — manageable, not systemic.
8. No material thesis-changing litigation/regulatory disclosed in the reviewed corpus.

Verdict (Changes): On balance STRENGTHEN, with elevated integration risk. The two-year arc is aggressive, largely successful scaling — AUM +49%, FRE +30%, a new Real Assets/digital-infra leg, reaffirmed ~20% growth algorithm, continued dividend compounding. Offsets are GCP integration/earn-out risk, the dilution that funded it, the Oct-2027 preferred conversion, and minor retail-redemption noise. Net positive; the GCP bet is the swing factor for the next two years.

9. Risk Analysis

The catastrophic-loss risk is genuinely low: ARES is capital-light with a conservatively levered, investment-grade corporate balance sheet, no owned-insurance spread risk, and a diversified, contractually locked fee base. The realistic downside is a cyclical one — a private-credit recession compressing growth and multiple together, made more painful by the high-beta starting point — not an existential one.

10. Valuation Discussion (Embedded Expectations)

10.1 The clean per-share build (FY2025)

Valuation must use non-GAAP per-share metrics on the fully-exchanged share count and a de-consolidated EV — GAAP EPS and the screen-reported 48–82x “P/E” / $53.8B EV are artifacts (the EV wrongly adds ~$9.6B non-recourse fund debt + $4.4B NCI; the P/E divides by a thin residual; P/B is negative from the Up-C structure).

10.2 Multiples at ~$134.90

10.3 Forward multiples (on management’s algorithm)

Carrying ~18% FRE / ~22% RI growth net of ~1.5% dilution: FRE/sh ~$6.30 (FY26E), ~$7.30 (FY27E), ~$8.45 (FY28E); after-tax RI/sh ~$5.55 / ~$6.65 / ~$7.95. At ~$134.90 that is ~21x FY26E and ~16–18x FY27–28E FRE — the de-rate has pulled the forward multiple back toward the group’s middle, if you believe the algorithm. The $730M / 23% embedded fee tailwind makes the mid-to-high-teens FRE growth near-contractual rather than a pure forecast — the strongest support under the stock.

10.4 Peer and own-history context

ARES carries the richest multiple in the group (~ties BX at the top; APO/KKR ~15–16x carry the insurance/spread drag; OWL ~12x is distressed; CG/TPG ~12–15x carry fundraising/carry concerns). It earns the premium the way BX does — a pure capital-light fee engine with no balance-sheet/insurance drag and the highest perpetual-capital mix — but its sector-low FRE margin caps how high the multiple can rationally go versus KKR. On its own history, ARES sits at the 77th percentile of price-to-sales and the 66th of the AZI composite — not cheap even after the drawdown. The selloff corrected an overshoot (FY24/early-25 P/S >9x, ~30x earnings); it did not create deep value.

10.5 Embedded expectations

Reverse-engineering the ~$135 price implies the market is paying for ~13–16% long-run RI growth — below management’s 20–25% near-term target but well above a mature 4–6% gatherer. The market prices ARES as a mid-teens secular compounder and has stopped paying the ~30x peak multiple. What must be true to justify ~$135: (1) FRE compounds mid-to-high teens (the embedded fees + steady fundraising get most of the way); (2) FRE margin holds ~46–48%; (3) no genuine credit cycle that impairs deployment, triggers broad redemptions, or marks down the book; (4) the dividend keeps compounding ~20%. Is the cycle priced correctly? Partially — the 33% de-rate has priced growth normalization and cycle risk, but not a full default recession (which would compress growth and multiple together). The market is pricing a soft landing.

A simple cross-check triangulates the same conclusion three ways. (a) Reverse-DCF on dividends. With a forward dividend of $5.40 growing ~20% for five years then fading to a ~5% terminal rate, discounted at ~9%, the implied value lands in the high-$120s-to-mid-$140s — i.e., the current price is fair on the income stream alone, requiring neither heroic growth nor a re-rating. (b) EV/management fees. At ~13.3x recurring management fees, ARES is paying up for fee quality but not absurdly so — the metric strips out lumpy carry and rewards exactly the durable fee base that is ARES’s strength; it is consistent with a premium but non-bubble valuation. © Earnings yield vs. growth. A ~4.0% forward FRE/RI-funded dividend yield plus ~16–20% FRE growth offers a total-return algebra in the high-teens if the multiple holds — attractive in absolute terms, but entirely contingent on the multiple not de-rating from its rich starting point. The three methods converge on the same verdict: ~$135 is a fair price for the quality and growth on offer, not a discounted one. The valuation does not need to be wrong for the stock to work; it needs the algorithm to keep compounding while the multiple merely holds — a reasonable but not bulletproof base case.

It is worth naming the asymmetry explicitly. Because ARES starts rich (77th-percentile P/S) and high-beta, the downside on a credit-cycle disappointment is a double compression — lower growth and a lower multiple — that the bear value zone (~$82–94) captures as a ~30%+ drawdown from here. The upside on a benign outcome is more muted — the multiple is unlikely to return to the ~30x euphoria of early 2025, so bull upside is driven mostly by earnings compounding into the existing multiple (~$158–173). That left-skewed payoff at the current price is the core reason the labeled opinion above prefers “accumulate on weakness” to “buy here”: the better risk/reward sits nearer the bear zone, where the same franchise can be owned with a genuine margin of safety.

10.6 Scenario value zones (not price targets)

The current ~$135 sits squarely in the base zone — priced for the soft landing it is most likely to get, with limited valuation cushion (bear is ~30%+ below) against moderate upside if the algorithm holds. Quality at a fair-to-full price, not a deep-value dislocation. (No price target; no recommendation.)

11. Variant Perception

Consensus view. ARES is a best-in-class, pure-play private-credit/alternative-credit compounder — the cleanest capital-light fee engine in the group (no insurance drag), with a reaffirmed 16–20% FRE / 20–25% RI / ~20% dividend algorithm and ~$730M of contractually embedded fee growth. After the ~33% de-rate, consensus accepts the quality and the algorithm but has stopped paying the peak multiple, now pricing a mid-teens compounder at ~21x forward with a 4%-and-growing yield. Consensus = “great franchise, fair price, cycle risk acknowledged.”

Strongest bull case. The private-credit secular shift (bank retreat, insurance/retail/wealth channels opening) is early, and ARES’s perpetual-capital mix makes its fee stream the most durable in the group. The embedded $730M fee tailwind deploys largely independent of fundraising, so mid-to-high-teens FRE growth is near-contractual. At ~16–18x FY27–28E FRE the stock is reasonably priced for a 20% RI compounder with a 4%-and-growing yield. The drawdown was a spread-panic overshoot (OWL contagion) on a franchise with no redemption problem of OWL’s scale — a quality name thrown out with distressed peers.

Strongest bear case. ARES is the richest multiple in the group on the lowest-margin model, still at the 77th percentile of its own ten-year valuation range after a 33% fall — not cheap, just less euphoric. The +0.31 CreditRisk and +1.24 Market factor loadings show it is a levered bet on tight credit spreads and risk appetite; a genuine default cycle hits deployment, fundraising, marks and the multiple simultaneously, with the bear value zone ~30% below current. The high payout and ~20% dividend CAGR depend on the algorithm holding, and a history of ~50% drawdowns means downside is severe when risk appetite turns.

The 3–5 assumptions that matter most, with falsification evidence:

Is consensus offsides? (factor-positioning read). Consensus is balanced, leaning cautious — not abandoned, not crowded-long. ARES still screens as an expensive growth name (negative Value loading -0.29; P/S 77th percentile), so there is no “left-for-dead” mispricing — unlike OWL (9.4% yield, ~12x DE), the genuine contrarian/distressed setup. And the momentum crowd has already exited (Momentum loading ≈ -0.08; -18% 1yr / -22% 6mo (-39% ann.)), with the m3 bounce (Sharpe 5.68) the early-recovery flicker. The variant-perception edge is therefore not “the market hates a great business” (it doesn’t) — it is the narrower bet on which side of assumption #3 (the credit cycle) resolves first. If benign, the forward multiple is reasonable and consensus is mildly too cautious; if a default cycle hits, the rich-on-own-history starting point plus high beta means downside is larger than consensus is pricing. The mispricing, if any, lives in the tails — not the center.

12. Fact vs. Interpretation

13. Open Questions

1. Does the FRE margin finally inflect? Will GCP synergies + the data-center turn from FRE-negative to FRE-accretive + back-office automation lift the sector-low ~42% margin toward peers — or is ~42% structural for a people-intensive credit model?
2. How deep is the private-credit cycle? Does the record ~6.0% industry default rate broaden into ARES’s direct-lending book (non-accruals, marks), or does diversification + dry powder hold it to “minimal impact” as management claims?
3. GCP’s real economics. What multiple did ARES ultimately pay once contingent earn-outs resolve, and does the logistics/digital-infra franchise scale into the fund pipeline as underwritten?
4. Deployment re-acceleration. US direct-lending deployment slowed on a 41% drop in middle-market M&A; how quickly does the flagship credit-fund pipeline convert to fee-paying AUM?
5. Dilution trajectory. After the Oct-2027 preferred conversion, does ARES ever turn to buybacks, or remain a permanent net issuer funding growth with equity?
6. Carry reservoir realization. Does the $762M of unrealized performance income convert into RI on a timeline that matters, adding torque the fee-centric model otherwise lacks?

14. What Must Be True

Bull case — what must be true:

• FRE compounds mid-to-high teens through 2027 as the $730M embedded fee base deploys and fundraising stays strong.
• FRE margin holds ~46–48% (or better), proving operating leverage rather than structural drag.
• The private-credit cycle stays benign for ARES — direct-lending non-accruals contained, redemptions limited to the quantified ~1% FPAUM, deployment re-accelerating.
• The dividend keeps compounding ~20%, confirming the RI trajectory and anchoring the ~4% yield.
• Falsification test (bull): Two-to-three consecutive quarters of sub-10% FRE growth, OR direct-lending non-accruals rising materially with broadening BDC/retail redemptions. Either breaks the “near-contractual mid-teens growth at a fair price” thesis.

Bear case — what must be true:

• A genuine private-credit default cycle impairs deployment, fundraising and marks, dragging FRE growth to high-single-digits.
• The sector-low FRE margin compresses toward the low-40s on spread/fee competition.
• The richest-in-group, 77th-percentile-of-own-history multiple de-rates toward the APO/KKR ~15–16x band, compressing growth and multiple together.
• The high-beta vehicle delivers another characteristic ~40–50% drawdown.
• Falsification test (bear): Q2–Q4’26 FRE growth tracking ≥18% with benign credit metrics WHILE the multiple holds ~20x — i.e., the algorithm proven through the cycle at a non-euphoric price — refutes the “rich, high-beta, cyclically-exposed” bear.

15. Source Appendix

See the full Source Appendix below (Appendix B) for the complete primary-source list. Principal sources: ARES FY2025 Form 10-K (filed 2026-02-25), Q1 2026 10-Q (2026-05-08), prior 10-Ks FY2021–FY2024, DEF 14A proxy (2026-04-21), Q4’25 and Q1’26 earnings-call transcripts, Form 4 insider filings (EDGAR, CIK 0001176948), and public market/valuation and factor data.

The body (sections 1–15) is deliberately position-free and carries no recommendation or price target; the sole exception is the labeled “Claude’s Take” opener, which is the author’s own subjective view and general information only, not investment advice.

APPENDIX A — Standard Diligence Questionnaire

Ares Management Corporation (NYSE: ARES) — supplemental to the research note. Report date 2026-06-14. Fact/Interpretation/Assumption labeled where it matters. Where a question does not map to an alternative-asset-manager model, the correct sector analog is given.

General

What thoughtful questions have other investors asked about this company? The recurring institutional debates: (1) Is the sector-low FRE margin (~42%) structural or a coiled spring? — the single most-asked question, because it separates “top-tier compounder” from “fast-growing lower-margin fee machine.” (2) How exposed is ARES to the private-credit cycle / retail-redemption wave? — management’s “~4.5% of FPAUM, ~1% downside” framing is the most-scrutinized number. (3) Is the GCP/GLP acquisition accretive at the price paid (~$3.9B, ~88% goodwill+intangibles)? (4) How should one value it — GAAP is useless, so the debate is P/FRE vs. P/after-tax-RI and what multiple a credit-heavy, low-carry manager deserves vs. KKR/BX. (5) Dilution — a permanent net issuer with no buyback; when, if ever, does that change?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: FRE/management fees are near a structural high (record $3.68B fees, $1.78B FRE) but are recurring and contractual, not cyclical-peak. The cyclical variable is deployment pace and performance income — both are currently below potential (US direct-lending deployment slowed on a 41% drop in middle-market M&A; net realized carry only ~$169M). So the durable earnings are high and rising; the cyclical earnings (carry, deployment) are arguably mid-to-low.

Driven by the external environment or internal actions? Both. Internal: fundraising, product launches, the GCP build-out, channel expansion (wealth/insurance). External: credit spreads, M&A volumes, interest rates, risk appetite — ARES screens as a high-beta, credit-spread-levered name (factor Market +1.24, CreditRisk +0.31).

How stable are revenues? Very, by industry standards — 93% of management fees come from perpetual or long-dated capital with multi-year contractual terms (Fact, 10-K). This is the franchise’s best quality attribute.

Outlook for products/services? Multiple credible growth legs: flagship credit super-cycle (ASOF III, ABF Pathfinder III, new senior-DL evergreen), wealth ($125B 2028 target), insurance/private-IG, digital infrastructure/data centers (~$900B TAM), secondaries.

How big will this market be — growing, shrinking, domestic or international? Global private markets are growing (private credit ~$1.7T → projected $2.6T+ by 2029); ARES is global (US, Europe, APAC, Middle East). Secular tailwinds: bank disintermediation, retirement/401(k) access, insurance outsourcing, wealth under-allocation (~3–4% individual allocation). The growth is real; the near-term cycle is the risk.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More competitive for assets (spread compression; direct-lending premium over syndicated loans narrowed to ~100bps) but consolidating toward scale leaders for capital (top-10 funds took ~46% of 2025 commitments). Net: favorable for scaled incumbents like ARES, unfavorable for sub-scale players.

How profitable is the business (ROIC, ROE)? GAAP ROIC/ROE are meaningless (consolidation artifacts; GAAP ROIC ~3.5%). On the relevant basis, ARES is highly profitable and capital-light: FRE $1,775M on ~$3.94B corporate debt and modest equity capital; after-tax RI ~$1,510M. Use FRE/RI, never GAAP returns.

How profitable is the industry — competitors, barriers to entry? A high-margin oligopoly-with-a-long-tail; barriers are scale, track record, distribution, and locked capital. ARES is #1 in direct lending; peers BX/APO/KKR/OWL/CG/TPG.

Can the business be easily understood? Moderately — the model (fees on AUM) is simple, but the GAAP consolidation, the FRE/RI/FRPR vocabulary, and the segment structure require work. The reporting opacity is itself a mild negative.

Can it be undermined by foreign low-cost labor? No — it is a relationship/judgment/capital business, not a cost-arbitrage one.

Do brands matter? Yes — “Ares” and “ARCC” are institutional brands; a 20-year track record is the brand, and it drives fundraising.

Nature of competition? Competition for LP capital and for deals; won via scale, track record, certainty of capital, and breadth of platform.

Customers’ switching costs? Real but moderate — capital is contractually locked (multi-year/perpetual), but LPs can decline the next vintage. Stickiness is structural, not preference lock-in.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Yes — the embedded fee-earning power of $78.8B of undeployed committed capital (~$730M of future fees) and the $762M reservoir of unrealized carried interest are economic assets not on the balance sheet. Also the indefinite-lived management contracts.

Off-balance-sheet liabilities? Fund commitments and guarantees exist but are modest relative to the firm; the larger nuance is the reverse — ~$9.6B of CLO/fund debt sits on the consolidated balance sheet but is non-recourse to ARES.

How conservative is the accounting? GAAP is conservative-but-opaque (heavy consolidation/NCI). The non-GAAP measures (FRE/RI) are the industry standard but flatter results by adding back ~$740M of SBC — the key accounting caveat.

How CapEx-hungry is the business? Very low — capital-light. FY2025 capex only ~$72M against $2.1B operating cash flow. Growth capital goes into fund co-investments and M&A, not physical assets.

Capital Allocation & Management

How much FCF does the business generate, and how is it used? Core operating cash flow $1,727M (FY2025, +58%); used primarily for the dividend ($1.76B total distributions), M&A (GCP), and fund co-investment. No buybacks.

Significant acquisitions recently? Yes — GCP International (GLP ex-China), closed 3/1/2025, ~$3.92B initial / up to ~$5.6B with earn-outs; plus Landmark (2021), AMP infra debt (2022), Crescent Point (2024).

Buying back shares? No — ARES is a net issuer (Class A +50% since 2020), funding M&A and comp with equity; the $1.46B preferred converts to ~30M shares Oct 1, 2027.

Issuing large amounts of new shares to insiders? SBC doubled to $740M in FY2025 (incl. ~$110M GCP immediate-vesting). Material and the biggest QoE caveat.

Compensation policy of directors/management? Fact (proxy): founders/co-founders (Arougheti, deVeer) take no salary or cash bonus — paid through carried interest and equity, aligned with LPs; non-founder NEOs get salary+bonus; carry vests over 5 years with clawback. Say-on-pay 92.3%.

Motivations of management? Strongly ownership-aligned — co-founder Ressler holds ~19.68% (fully-exchanged); founders’ wealth is in the stock and fund carry. Governance trade-off: founder-controlled voting.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — ARES is a C-corporation issuing a Form 1099 (not a K-1), unlike legacy alt-manager partnership structures. This broadens its investor base (index/40-Act eligible) and is a structural positive vs. K-1 issuers.

Dividend policy? Variable dividend set against after-tax FRE (not GAAP); $1.35/qtr ($5.40 annualized, +20% YoY), ~4.0% forward yield, ~60–70% payout, guided to ~20% annual growth.

How profitable is the business? Highly, on FRE/RI; sector-low FRE margin (~42%) is the one blemish.

Is net income diverging from cash from operations? On GAAP, yes (consolidation noise); on the relevant basis, operating cash flow ($2.1B) exceeds RI ($1.85B) — healthy conversion, with the SBC add-back the caveat.

Risks & Downside

What factors would cause the stock to decline? A private-credit default cycle (deployment slowing, redemptions broadening, marks); FRE-margin disappointment; multiple de-rating from the richest-in-group, 77th-percentile-of-own-history starting point; a risk-off move (β≈1.55). See the §9 risk matrix.

Risk of a catastrophic loss? Low. Capital-light, investment-grade corporate balance sheet (~2.2x FRE), no owned-insurance spread risk, diversified contractually locked fee base. The realistic downside is cyclical (a ~30–50% drawdown — characteristic for this high-beta name), not existential.

Chance of a total loss? Very low. No scenario in the evidence base points to insolvency; the non-recourse nature of fund/CLO debt insulates the parent.

Recent News & Events

Has the business environment changed recently? Yes — the private-credit redemption wave (late-2025/2026) and record ~6.0% industry default rate (Fitch, Apr 2026) are the live macro change; ARES fell in sympathy with distressed peer OWL but with far smaller direct exposure. The AZI news feed (June 2026) shows ARES grouped with TPG/Artisan in a sector-wide down-day — a sector move, not company-specific bad news.

Significant acquisitions? GCP International (closed 3/1/2025) — transformational; created APAC real estate equity + a digital-infra platform.

Change in accounting policies? Q1 2025 segment realignment (real estate + infrastructure → Real Assets Group; interest-expense allocation change) — affects segment comparability, not the consolidated numbers.

Recent changes — new markets, facilities, management? New 401(k)/retirement direct-lending product; continued wealth/insurance build-out; dual Co-President structure; dissolution of the Executive Management Committee (Feb 2025, duties to the full Board); added to the S&P 500 (Dec 2025).

APPENDIX B — Source Appendix

Ares Management Corporation (NYSE: ARES). Report date 2026-06-14. Primary sources first. CIK 0001176948. All SEC filings accessed via EDGAR and mirrored locally; ROIC/AZI/FactorsToday accessed 2026-06-14.

Primary — SEC filings (EDGAR, CIK 0001176948)

1. Form 10-K, FY2025 — filed 2026-02-25. Business §, segment AUM/FPAUM tables, fee-rate schedules, perpetual-capital & AUM-not-yet-paying-fees ($730M/23%) disclosures, FPAUM rollforward, FRE/RI segment reconciliations, balance sheet & Note 7 (debt: $3.94B corporate vs. $9.6B non-recourse CLO/fund), GCP acquisition note, SBC/equity-comp ($740.5M), dividend policy. https://www.sec.gov/Archives/edgar/data/1176948/000162828026011413/ares-20251231.htm
2. Form 10-Q, Q1 2026 — filed 2026-05-08. Q1’26 FRE $464.4M / RI $502.7M; management fees >$1.0B (+22%). https://www.sec.gov/Archives/edgar/data/1176948/000162828026032990/ares-20260331.htm
3. Form 10-K, FY2021–FY2024 — filed 2022-02-28, 2023-02-24, 2024-02-27, 2025-02-27. Five-year FRE/RI/management-fee trend.
4. DEF 14A proxy — filed 2026-04-21. Executive comp philosophy/elements, NEO pay, Ressler ~19.68% fully-exchanged stake, say-on-pay 92.3%, committee dissolutions. https://www.sec.gov/Archives/edgar/data/1176948/000162828026026286/ares-20260420.htm
5. Annual Report (ARS) — filed 2026-04-21 (FY2025). aresars2025annualreport.pdf
6. Earnings 8-Ks — 2026-02-05 (Q4/FY2025), 2026-05-01 (Q1’26), 2025-11-03 (Q3’25) — non-GAAP FRE/RI detail.
7. Form 4 insider filings — EDGAR, 2024–2026 (~386 filings). Director Ashish Bhutani open-market purchase 10,000 sh @ $126.61 (2026-02-06); Director Judy Olian 480 sh @ $124.43 (2026-02-20); CEO Arougheti charitable gift (code G) 425,000 sh (2025-12-18); CFO Phillips grant/tax-withhold (code A/F, 2026-01-31); GC Sagati Aghili 10b5-1 sells (2025-10 / 2026-02).
8. Capital-structure 8-Ks / S-3ASR — Series B 6.75% mandatory convertible preferred ($1.46B, converts Oct 1 2027), 2024 follow-on, senior notes, revolver upsize to $1.84B (April 2025).

Primary — Earnings-call transcripts (ROIC.ai MCP)

9. Q4/FY2025 earnings call — 2026-02-05. 20% dividend hike to $1.35/qtr; FY2025 results; multi-year targets (16–20% FRE / 20–25% RI / ~20% dividend CAGR); private-credit cycle commentary. Local copy: output/ARES/transcripts/ARES_2025_Q4_transcript.txt.
10. Q1 2026 earnings call — 2026-05-01. Q1’26 results; management fees >$1.0B; retail-redemption quantification (~4.5% FPAUM, ~1% downside, >95% did not redeem); deployment/M&A commentary; data-center fund first close; insurance/IG/ABF build-out. Local copy: output/ARES/transcripts/ARES_2026_Q1_transcript.txt.

Quantitative data sources

11. ROIC.ai MCP (accessed 2026-06-14) — company profile; income statement / balance sheet / cash flow (FY2020–FY2025); profitability, per-share, valuation multiples (FY2015–FY2025); enterprise value. Used to confirm GAAP distortion (P/E 48–82x, EV $53.8B incl. non-recourse debt + NCI — discarded) and own-history P/S range (FY25 6.27x vs. 10yr ~1.1–9.0x). Third-party aggregated data; reconciled to filings.
12. AZI valuation_index (accessed 2026-06-14) — own-history percentiles: composite 66.3, P/E 61.2, P/B 60.7, P/S 77.1; price $134.90 (2026-06-12). P/E percentile distorted by GAAP — P/S used as the cleanest own-history gauge.
13. AZI news feed (accessed 2026-06-14) — June 2026 sector down-day (ARES grouped with TPG/Artisan; BX/Carlyle); confirmed a sector move, not company-specific news.
14. AZI price history CSV (accessed 2026-06-14) — OHLCV + 21/50/200-day EMA + beta/alpha. 2025 peak ~$198 (Jan), 2026 trough ~$96.50 (Mar), current $134.90; price reclaimed 200-day EMA (~$135) on 2026-06-12.
15. FactorsToday factor model (data 2026-06-12, pulled 2026-06-14) — stock-loadings (Market +1.24, CreditRisk +0.31, Value −0.29, Momentum ≈ −0.08; R² ~0.52); leaderboard (10yr +30.3% CAGR, Sharpe 0.77, max DD −49.7%; 1yr −18%; 6mo −22% (−39% ann.); 3mo strong bounce); stock-info (β 1.55, α −0.138, rs_6m −22.4%, rs_12m −17.0%, div yield 4.12%); related-stocks (OWL 0.97 closest; KKR/BX/TPG/APO/HLNE/STEP/AMG). Third-party statistical estimates; loadings/returns are facts, “continue/revert” is interpretation.

Peer cross-read (public alternative-asset managers)

16. Public peer filings & disclosures used for comparison and sector framing: Blue Owl (OWL — closest comp), KKR, Apollo (APO), Blackstone (BX), Carlyle (CG) and TPG — public 10-K/10-Q filings, earnings releases and investor materials.

Industry / external data referenced

17. Fitch — US private-credit default rate ~6.0% (April 2026).
18. Preqin / sell-side private-credit market sizing (~$1.7T → projected $2.6T+ by 2029).
19. Executive Order 14330 (Aug 2025) and DOL/EBSA proposed safe-harbor rule (Mar 2026) on defined-contribution access to private assets.

Management commentary from transcripts and IR materials is treated as hypothesis, validated against filings and external data. No figure from any third-party aggregator is used as a price target.